Edwards Lifesciences (EW) delivered mixed results in FY2026 on revenue of $34.6B versus the $33.8B estimate (+16.3% YoY) and EPS of $2.59. Below is the full Edwards Lifesciences earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
$34.6B (vs $33.8B est · +2.3% surprise · +16.3% YoY)
EPS
$2.59 (vs $2.64 est · -1.9% surprise · +39.5% YoY)
Share price
$527.00 (-2.4%)
Market cap
$1.80T
What you'll find
Next Edwards Lifesciences (EW) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Edwards Lifesciences reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Edwards Lifesciences (EW)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Edwards Lifesciences's next earnings date?
Edwards Lifesciences's (EW) next scheduled earnings date is Feb 4, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Edwards Lifesciences (EW) beat or miss earnings?
In FY2026, Edwards Lifesciences (EW) posted mixed results — revenue of $34.6B versus the $33.8B estimate (+2.3% surprise) and EPS of $2.59 versus $2.64 expected (-1.9% surprise). Magnisto decodes every Edwards Lifesciences (EW) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Edwards Lifesciences (EW) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Edwards Lifesciences (EW), anchored to the current $527.00 share price, so you can weigh the bull, base and bear cases for Edwards Lifesciences side by side.
Is Edwards Lifesciences (EW) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Edwards Lifesciences fits your own thesis and risk profile. This is research, not investment advice.